Written by Taylor Woosley, Staff Writer. Results of the systematic review and meta-analysis of 10 RCTs shows that administration of ALA significantly improved total symptoms’ score and neurological disability score outcomes in diabetic subjects with DSPN. (more…)
Written by Taylor Woosley, Staff Writer. 2-month supplementation of both 400 mg/day and 800 mg/day of ALA significantly reduced pain management amongst subjects, with both groups experiencing changes in pain scores, decreasing from moderate to mild pain. (more…)
Written by Chrystal Moulton, Staff Writer. Supplementation with alpha lipoic acid saw significant reduction in symptoms of neuropathic pain observed in patients with diabetes mellitus (P <0.001). (more…)
Written by Angeline A. De Leon, Staff Writer. An individualized supplement of alpha-lipoic acid, carnosine, and thiamine was able to maximize the potential antidiabetic activity in type 2 diabetic recipients by effectively reducing glucose concentration, and potentially increasing insulin production from the pancreas.
(more…)
Written by Angeline A. De Leon, Staff Writer. Three months of alpha lipoic acid supplementation significantly improved vascular tone and clinical and metabolic risk factors, offering a potential beneficial effect on cardiovascular health in overweight and obese youth. (more…)
Written by Greg Arnold, DC, CSCS. A two year supplementation with 1200 mg of lipoic acid significantly reduced (68%) brain atrophy in the 27 study participants with multiple sclerosis compared to the control group.
Written by Greg Arnold, DC, CSCS. When taken daily, 600 mg of alpha lipoic acid and 140 IU of SOD reduced the number of those who said “I have difficulty getting out of my chair due to back pain” by 94%. (more…)
Written by Jessica Patella, ND. Alpha Lipoic acid at 600mg per day reduced four major pain symptoms in those with diabetic neuropathy by 62%. (more…)
Written by Dr. Patrick Massey, MD, PhD. Alpha Lipoic reduced the symptoms of diabetic neuropathy by 50% (more…)
